Starzl T E, Koep L, Porter K A, Schroter G P, Weil R, Hartley R B, Halgrimson C G
Arch Surg. 1980 Jul;115(7):815-9. doi: 10.1001/archsurg.1980.01380070009002.
Twenty-three recent cases of orthotopic liver transplantation were individually reviewed in an effort to determine why survival had declined from the 50% one-year survival rate of an immediately precedent series. In the series of 23, only six (26%) achieved one-year survival. Faulty case selection, technical complications, the use of damaged organs, and complications of immunosuppression were the main causes of death. Attention was directed to the possible use of preoperative lymphoid depletion to improve the effectiveness and safety of immunosuppression.
对最近23例原位肝移植病例进行了个案回顾,以确定为何生存率较前一组病例的一年生存率50%有所下降。在这23例病例中,只有6例(26%)存活了一年。病例选择不当、技术并发症、使用受损器官以及免疫抑制并发症是主要死亡原因。研究关注了术前淋巴细胞清除可能用于提高免疫抑制的有效性和安全性。